Home
>
National Drug Code (NDC)
>
Inapsine
Inapsine - 17478-531-02 - (Droperidol)
Drug Information of Inapsine
| Product NDC: | 17478-531 |
| Proprietary Name: | Inapsine |
| Non Proprietary Name: | Droperidol |
| Active Ingredient(s): | 2.5 mg/mL & nbsp; Droperidol |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Inapsine
| Product NDC: | 17478-531 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016796 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960701 |
Package Information of Inapsine
| Package NDC: | 17478-531-02 |
| Package Description: | 25 VIAL in 1 CARTON (17478-531-02) > 2 mL in 1 VIAL |
NDC Information of Inapsine
| NDC Code | 17478-531-02 |
| Proprietary Name | Inapsine |
| Package Description | 25 VIAL in 1 CARTON (17478-531-02) > 2 mL in 1 VIAL |
| Product NDC | 17478-531 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Droperidol |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19960701 |
| Marketing Category Name | NDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | DROPERIDOL |
| Strength Number | 2.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |
